291 related articles for article (PubMed ID: 23539383)
1. Novel therapeutic strategies in adult acute lymphoblastic leukemia--a focus on emerging monoclonal antibodies.
Daver N; O'Brien S
Curr Hematol Malig Rep; 2013 Jun; 8(2):123-31. PubMed ID: 23539383
[TBL] [Abstract][Full Text] [Related]
2. New monoclonal antibodies for the treatment of acute lymphoblastic leukemia.
Farhadfar N; Litzow MR
Leuk Res; 2016 Oct; 49():13-21. PubMed ID: 27521873
[TBL] [Abstract][Full Text] [Related]
3. Antibody therapy for acute lymphoblastic leukemia.
Portell CA; Advani AS
Curr Hematol Malig Rep; 2012 Jun; 7(2):153-9. PubMed ID: 22422550
[TBL] [Abstract][Full Text] [Related]
4. Current status of antibody therapy in ALL.
Ai J; Advani A
Br J Haematol; 2015 Feb; 168(4):471-80. PubMed ID: 25382151
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies in acute lymphoblastic leukemia.
Jabbour E; O'Brien S; Ravandi F; Kantarjian H
Blood; 2015 Jun; 125(26):4010-6. PubMed ID: 25999456
[TBL] [Abstract][Full Text] [Related]
6. Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives.
Franca R; Favretto D; Granzotto M; Decorti G; Rabusin M; Stocco G
Curr Med Chem; 2017; 24(11):1050-1065. PubMed ID: 28088906
[TBL] [Abstract][Full Text] [Related]
7. Antibody-based therapies in B-cell lineage acute lymphoblastic leukaemia.
Le Jeune C; Thomas X
Eur J Haematol; 2015 Feb; 94(2):99-108. PubMed ID: 24981395
[TBL] [Abstract][Full Text] [Related]
8. Novel antibody therapy in acute lymphoblastic leukemia.
Kochuparambil ST; Litzow MR
Curr Hematol Malig Rep; 2014 Jun; 9(2):165-73. PubMed ID: 24623281
[TBL] [Abstract][Full Text] [Related]
9. Progress and Innovations in the Management of Adult Acute Lymphoblastic Leukemia.
Jabbour E; Pui CH; Kantarjian H
JAMA Oncol; 2018 Oct; 4(10):1413-1420. PubMed ID: 29931220
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapy with monoclonal antibodies in acute lymphoblastic leukemia.
Hoelzer D
Curr Opin Oncol; 2013 Nov; 25(6):701-6. PubMed ID: 24097105
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody therapy with rituximab for acute lymphoblastic leukemia.
Thomas DA; O'Brien S; Kantarjian HM
Hematol Oncol Clin North Am; 2009 Oct; 23(5):949-71, v. PubMed ID: 19825447
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies: new chance in the management of B-cell acute lymphoblastic leukemia.
Shi Z; Zhu Y; Zhang J; Chen B
Hematology; 2022 Dec; 27(1):642-652. PubMed ID: 35622074
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies and immune therapies for adult precursor B-acute lymphoblastic leukemia.
Sikaria S; Aldoss I; Akhtari M
Immunol Lett; 2016 Apr; 172():113-23. PubMed ID: 26921100
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody-based therapies in the treatment of acute lymphoblastic leukemia.
Litzow MR
Am Soc Clin Oncol Educ Book; 2013; ():294-9. PubMed ID: 23714527
[TBL] [Abstract][Full Text] [Related]
15. Novel targets for treatment of adult acute lymphocytic leukemia.
Kasner MT
Curr Hematol Malig Rep; 2010 Oct; 5(4):207-12. PubMed ID: 20680526
[TBL] [Abstract][Full Text] [Related]
16. The ABCs of Immunotherapy for Adult Patients With B-Cell Acute Lymphoblastic Leukemia.
Horvat TZ; Seddon AN; Ogunniyi A; King AC; Buie LW; Daley RJ
Ann Pharmacother; 2018 Mar; 52(3):268-276. PubMed ID: 29025266
[TBL] [Abstract][Full Text] [Related]
17. Emerging biological therapies to treat acute lymphoblastic leukemia.
Huguet F; Tavitian S
Expert Opin Emerg Drugs; 2017 Mar; 22(1):107-121. PubMed ID: 27820973
[TBL] [Abstract][Full Text] [Related]
18. Targeting CD22 in B-cell malignancies: current status and clinical outlook.
Sullivan-Chang L; O'Donnell RT; Tuscano JM
BioDrugs; 2013 Aug; 27(4):293-304. PubMed ID: 23696252
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies for the treatment of acute lymphocytic leukemia: A literature review.
Pourmontaseri H; Habibzadeh N; Entezari S; Samadian F; Kiyani S; Taheri M; Ahmadi A; Fallahi MS; Sheikhzadeh F; Ansari A; Tamimi A; Deravi N
Hum Antibodies; 2022; 30(3):117-130. PubMed ID: 35662114
[TBL] [Abstract][Full Text] [Related]
20. Antibody based therapy in relapsed acute lymphoblastic leukemia.
Jammal N; Chew S; Jabbour E; Kantarjian H
Best Pract Res Clin Haematol; 2020 Dec; 33(4):101225. PubMed ID: 33279181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]